Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 36.79
+0.41 (1.13%)
May 12, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 5.8 billion as of May 12, 2026. Its market cap has increased by 43.15% in one year.
Market Cap
5.80B
Enterprise Value
5.63B
Revenue
917.99M
Ranking
n/a
PE Ratio
34.72
Stock Price
36.79
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 5.80B, an increase of 3.35%. That is a compound annual growth rate of 0.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 5.73B | -9.33% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 6.51B |
| Novogene | 6.48B |
| Hangzhou Biotest Biotech | 6.35B |
| PharmaResources (Shanghai) | 6.11B |
| R&G PharmaStudies | 5.98B |
| Shenzhen Weiguang Biological Products | 5.92B |
| Jiangsu Bioperfectus Technologies | 5.77B |
| Lifecome Biochemistry | 5.73B |